Xu C - Search Results

1

In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice.

Hu R, Shen G, Yerramilli UR, Lin W, Xu C, Nair S, Kong AN. Hu R, et al. Among authors: xu c. Arch Pharm Res. 2006 Oct;29(10):911-20. doi: 10.1007/BF02973914. Arch Pharm Res. 2006. PMID: 17121188

2

Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells.

Gopalakrishnan A, Xu CJ, Nair SS, Chen C, Hebbar V, Kong AN. Gopalakrishnan A, et al. Among authors: xu cj. Arch Pharm Res. 2006 Aug;29(8):633-44. doi: 10.1007/BF02968247. Arch Pharm Res. 2006. PMID: 16964758

3

Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin.

Shen G, Xu C, Hu R, Jain MR, Gopalkrishnan A, Nair S, Huang MT, Chan JY, Kong AN. Shen G, et al. Among authors: xu c. Mol Cancer Ther. 2006 Jan;5(1):39-51. doi: 10.1158/1535-7163.MCT-05-0293. Mol Cancer Ther. 2006. PMID: 16432161

4

Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.

Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Hu R, et al. Among authors: xu c. Cancer Lett. 2006 Nov 18;243(2):170-92. doi: 10.1016/j.canlet.2005.11.050. Epub 2006 Mar 3. Cancer Lett. 2006. PMID: 16516379

5

Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray.

Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Hu R, et al. Among authors: xu c. Life Sci. 2006 Oct 12;79(20):1944-55. doi: 10.1016/j.lfs.2006.06.019. Epub 2006 Jun 20. Life Sci. 2006. PMID: 16828809

6

Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice.

Khor TO, Hu R, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Nair S, Reddy B, Chada K, Kong AN. Khor TO, et al. Among authors: xu c. Biopharm Drug Dispos. 2006 Dec;27(9):407-20. doi: 10.1002/bdd.522. Biopharm Drug Dispos. 2006. PMID: 16952200

7

Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.

Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R, Jain MR, Lin W, Keum YS, Liew C, Chan JY, Kong AN. Nair S, et al. Among authors: xu c. Pharm Res. 2006 Nov;23(11):2621-37. doi: 10.1007/s11095-006-9099-x. Epub 2006 Sep 13. Pharm Res. 2006. PMID: 16969697

8

Induction of phase I, II and III drug metabolism/transport by xenobiotics.

Xu C, Li CY, Kong AN. Xu C, et al. Arch Pharm Res. 2005 Mar;28(3):249-68. doi: 10.1007/BF02977789. Arch Pharm Res. 2005. PMID: 15832810 Review.

9

Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein.

Shen G, Hebbar V, Nair S, Xu C, Li W, Lin W, Keum YS, Han J, Gallo MA, Kong AN. Shen G, et al. Among authors: xu c. J Biol Chem. 2004 May 28;279(22):23052-60. doi: 10.1074/jbc.M401368200. Epub 2004 Mar 13. J Biol Chem. 2004. PMID: 15020583 Free article.

10

Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.

Xu C, Shen G, Chen C, Gélinas C, Kong AN. Xu C, et al. Oncogene. 2005 Jun 30;24(28):4486-95. doi: 10.1038/sj.onc.1208656. Oncogene. 2005. PMID: 15856023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,799 results

Search Page

Filters